Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

More Chantal-shuttered stores are reopening in Chapel Hill
Everything that didn't float was destroyed, but Great Outdoor Provision Co. could finally reopen at Chapel Hill's Eastgate Crossing shopping center later this month. Meanwhile,...
Mon Oct 13, 2025

UNC English professor Florence Dore balances academics and rock
UNC English Professor Florence Dore teaches students about Southern fiction and songwriting. But when Dore isn’t in the classroom, she’s spending her time preparing for...
Sun Oct 12, 2025

UNC’s Kenan Stadium Selected As Banana Ball World Tour Host Site
The Savannah Bananas will be coming to North Carolina's Kenan Stadium as one of its sites for the 2026 Banana Ball World Tour. The Savannah...
Fri Oct 10, 2025

Chapel Hill-Carrboro Openings, Closings and Updates in July-September 2025
The top story of July, and one of the biggest of all 2025, is the historical rainfall and flooding caused by Tropical Depression Chantal in...
Fri Oct 10, 2025